A recent trial found that nearly 60% of patients with a rare condition called eosinophilic granulomatosis with polyangiitis (EGPA) went […]
Parabilis Medicines, previously known as FogPharma, is a biotech company that has changed its name to better reflect its mission.
At the Outsourcing in Clinical Trials Conference in New England, the US Customs and Border Protection (CBP) highlighted common legal
Novartis and Apellis Pharmaceuticals are competing to develop treatments for a rare kidney disease. Both companies recently shared promising results
MVA-BN, a vaccine for mpox (monkeypox) and smallpox, is sold under the name Jynneos in the US and Imvanex in
The US is considering approving VTAMA cream, a treatment for skin conditions, for atopic dermatitis. Organon has bought Dermavant Sciences,
